This inventor holds 27 USPTO granted patents and 3 published patent applications and 1 EPO patent, primarily in Anti-Cancer Therapeutics. Top assignees: Tapestry Pharmaceuticals, Inc., Advanced Cancer Therapeutics, LLC, University Of Louisville Research Foundation, Inc.. Active years: 1998-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- The Woodlands, TX (US) (1998 - 2009)
- Boulder, CO (US) (2012 - 2013)
- Louisville, KY (US) (2013 - 2024)
Company Filing History:
14 out of 23 
4 out of 7 
4 out of 398 
Years Active: 1998-2026
Areas of Expertise:
Title: Innovations in Oncology: The Contributions of Gilles Hugues Tapolsky
Introduction
Gilles Hugues Tapolsky, based in Louisville, KY, has made significant advancements in the field of oncology through his innovative research and numerous patents. With a total of 25 patents to his name, his work primarily focuses on the development of biologically active compounds for cancer treatment.
Latest Patents
Among his latest patents are noteworthy inventions that aim to improve cancer therapies. One such patent is for "Biologically active taxane analogs and methods of treatment by oral administration." This invention pertains to a novel chemical compound used for treating cancer, including compositions that incorporate this compound. The patent describes methods of manufacture and the potential for combinations with other therapeutic agents. Another significant patent is related to "Taxane analogs for the treatment of brain cancer." This patent outlines compounds and methods specifically designed for administering to mammals, which stabilize tubulin dimers or microtubules at the G2-M interface during mitosis—crucial for the effective treatment of brain cancer.
Career Highlights
Throughout his career, Gilles Hugues Tapolsky has contributed to various esteemed organizations, including Tapestry Pharmaceuticals, Inc. and Virotex Corporation. His innovative approach and dedication to cancer research have positioned him as a prominent figure in the pharmaceutical industry.
Collaborations
Collaboration has been key to Tapolsky's research endeavors. He has worked alongside notable colleagues such as James D. McChesney and John L. Marshall. Their collective expertise has facilitated the development of groundbreaking treatments that hold promise for cancer patients.
Conclusion
Gilles Hugues Tapolsky's contributions to cancer research through innovative patents and collaborations highlight his commitment to improving treatment outcomes. His pioneering work in taxane analogs and the development of novel therapeutic agents reflects the potential of innovation in transforming cancer therapies, underscoring the importance of continued research in this critical field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile